All Stories

  1. Using quantitative modeling tools to assess pharmacokinetic bias in epidemiological studies showing associations between biomarkers and health outcomes at low exposures

    Article • Environmental Research, June 2021, Elsevier

    Dr Pankajini Mallick

  2. Physiologically Based Pharmacokinetic Modeling in Risk Assessment: Case Study With Pyrethroids

    Article • Toxicological Sciences, May 2020, Oxford University Press (OUP)

    Dr Pankajini Mallick, Ronald N. Hines

  3. Quantitative bias analysis of the association between subclinical thyroid disease and two perfluoroalkyl substances in a single study

    Article • Environmental Research, March 2020, Elsevier

    Dr Pankajini Mallick

  4. Population Life-course exposure to health effects model (PLETHEM): An R package for PBPK modeling

    Article • Computational Toxicology, February 2020, Elsevier

    Dr Pankajini Mallick

  5. The Evolving Druggability and Developability Space: Chemically Modified New Modalities and Emerging Small Molecules

    Article • The AAPS Journal, January 2020, Springer Science + Business Media

    Dr Pankajini Mallick

  6. Development and Application of a Life-Stage Physiologically Based Pharmacokinetic (PBPK) Model to the Assessment of Internal Dose of Pyrethroids in Humans

    Article • Toxicological Sciences, October 2019, Oxford University Press (OUP)

    Ronald N. Hines, Dr Pankajini Mallick

  7. Impact of diet on irinotecan toxicity in mice

    Article • Chemico-Biological Interactions, August 2018, Elsevier

    Dr Pankajini Mallick

  8. Utilizing in vitro transporter data in IVIVE-PBPK: an overview

    Article • ADMET & DMPK, December 2017, International Association of Physical Chemists (IAPC)

    Dr Pankajini Mallick

  9. Role of Toll-like receptor 4 in drug-drug interaction between paclitaxel and irinotecan in vitro

    Article • Toxicology in Vitro, June 2017, Elsevier

    Dr Pankajini Mallick

  10. Implications of drug-metabolizing enzymes in biologics–small molecule drug (SMD) interactions

    Article • Expert Opinion on Drug Metabolism & Toxicology, February 2017, Taylor & Francis

    Dr Pankajini Mallick

  11. In Vitro Approaches to Study Regulation of Hepatic Cytochrome P450 (CYP) 3A Expression by Paclitaxel and Rifampicin

    Article • January 2016, Springer Science + Business Media

    Dr Pankajini Mallick

  12. Impact of obesity on accumulation of the toxic irinotecan metabolite, SN-38, in mice

    Article • Life Sciences, October 2015, Elsevier

    Dr Pankajini Mallick

  13. Effect of pentoxifylline on the pharmacokinetics of rosiglitazone in Wistar rats

    Article • January 2008, Portico

    Dr Pankajini Mallick